Amazing Grace Biotech Corp

MabSwitch Inc. is a biotechnology company based in Van Nuys, CA, focused on developing and commercializing innovative products utilizing affinity switches for antibodies. Their pioneering approach aims to enhance patient outcomes through next-generation immunotherapeutics, diagnostics, and immunoaffinity reagents. Through their proprietary Universal Allosteric Linker and Switch Module for Antibodies (UNASMA) technology, MabSwitch seeks to address significant challenges in the application of antibodies, such as regulating binding affinity in therapeutic and diagnostic settings. With the increasing demand for antibody-based products, the company is positioned at the forefront of biotechnology advancements. Generated from the website

Sanguine Biosciences Inc, based in Sherman Oaks, CA, specializes in providing a comprehensive range of biospecimens, including leukopaks, PBMCs, plasma, serum, and whole blood from both healthy individuals and those diagnosed with over 100 diseases. Their innovative direct-to-donor model enhances access to high-quality biosamples, facilitating more inclusive and effective biomedical research. The company is dedicated to accelerating translational research by prioritizing donor engagement and support, offering a patient-centered approach that allows individuals to easily participate in medical studies from the comfort of their own homes. With a strong emphasis on transparency, privacy, and appropriate compensation, Sanguine ensures a better experience for donors while delivering impactful research outcomes. Generated from the website

MT Group is a biospecimen contract research organization (CRO) based in Van Nuys, CA, dedicated to enhancing human health by providing high-quality biospecimen products and services to pharmaceutical, biotechnology, and diagnostic companies. With over 20 years of experience and a network of 150 collection sites, they specialize in custom collections and comprehensive clinical annotation to support biomarker discovery and validation. Committed to quality and partnership, MT Group ensures that their biospecimens meet rigorous standards and are backed by complete clinical metadata, facilitating impactful translational research. Their approach emphasizes building long-term relationships with clients, resulting in a significant portion of their business coming from repeat partnerships. Generated from the website